PeptideDB

Frovatriptan-d3 (hydrochloride)

CAS: F: C14H15D3ClN3O W: 282.78

Frovatriptan-d3 (hydrochloride) is the deuterium labeled Frovatriptan. Frovatriptan is a potent 5-HT1B//D receptor agoni
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Frovatriptan-d3 (hydrochloride) is the deuterium labeled Frovatriptan[1]. Frovatriptan is a potent 5-HT1B//D receptor agonist and has the highest 5-HT1B potency in the triptan class. Frovatriptan is apparently cerebroselective. Frovatriptan is efficacious and even superior in some endpoints also when taken during the headache phase in migraine attacks with aura[2].
Invitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
Name Frovatriptan-d3 (hydrochloride)
Formula C14H15D3ClN3O
Molar Mass 282.78
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Stefan Evers, et al. Efficacy of frovatriptan as compared to other triptans in migraine with aura.